ALLMedicine™ Spasmodic Dysphonia Center
Research & Reviews 465 results
https://doi.org/10.1016/j.amjoto.2021.102940
American Journal of Otolaryngology; Nerurkar NK, Agrawal D et. al.
Feb 5th, 2021 - Spasmodic dysphonia (SD) is a neurological condition of the larynx characterised by task specific, involuntary spasms of the intrinsic laryngeal muscles causing frequent voice breaks during speech. The current treatment modality involves Botulinum...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792454
Tremor and Other Hyperkinetic Movements (New York, N.Y.); Evidente VGH, Ponce FA et. al.
Jan 28th, 2021 - To date, there are only six published reports of adductor spasmodic dysphonia (SD) responding to awake thalamic deep brain stimulation (DBS). We retrospectively reviewed cases of Essential Tremor (ET) with SD that were seen in our center from 2012...
https://doi.org/10.1016/j.jvoice.2020.12.047
Journal of Voice : Official Journal of the Voice Foundation; Vanderaa V, Vinney LA
Jan 24th, 2021 - The purpose of this research was to determine whether an association between laryngeal hypersensitivity (LH) and spasmodic dysphonia (SD) exists using the LH Questionnaire (LHQ). This study also explored the prevalence of self-reported upper respi...
https://doi.org/10.1111/ene.14714
European Journal of Neurology; Hyodo M, Nagao A et. al.
Jan 4th, 2021 - Botulinum toxin (BT) injection into the laryngeal muscles has been a standard treatment for spasmodic dysphonia (SD). However, few high-quality clinical studies have appeared, and BT is used off-label in most countries. We performed a multicenter,...
https://doi.org/10.1002/mus.27161
Muscle & Nerve; Dwyer CD, Leclerc AA et. al.
Dec 31st, 2020 - Despite use of qualitative laryngeal electromyography (LEMG) guided botulinum toxin A (BoNT-A) injection for treatment of adductor spasmodic dysphonia (AdSD), unsatisfactory injections and complete "misses" remain problematic. We aimed to determin...
Clinicaltrials.gov 469 results
https://doi.org/10.1016/j.amjoto.2021.102940
American Journal of Otolaryngology; Nerurkar NK, Agrawal D et. al.
Feb 5th, 2021 - Spasmodic dysphonia (SD) is a neurological condition of the larynx characterised by task specific, involuntary spasms of the intrinsic laryngeal muscles causing frequent voice breaks during speech. The current treatment modality involves Botulinum...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792454
Tremor and Other Hyperkinetic Movements (New York, N.Y.); Evidente VGH, Ponce FA et. al.
Jan 28th, 2021 - To date, there are only six published reports of adductor spasmodic dysphonia (SD) responding to awake thalamic deep brain stimulation (DBS). We retrospectively reviewed cases of Essential Tremor (ET) with SD that were seen in our center from 2012...
https://doi.org/10.1016/j.jvoice.2020.12.047
Journal of Voice : Official Journal of the Voice Foundation; Vanderaa V, Vinney LA
Jan 24th, 2021 - The purpose of this research was to determine whether an association between laryngeal hypersensitivity (LH) and spasmodic dysphonia (SD) exists using the LH Questionnaire (LHQ). This study also explored the prevalence of self-reported upper respi...
https://doi.org/10.1111/ene.14714
European Journal of Neurology; Hyodo M, Nagao A et. al.
Jan 4th, 2021 - Botulinum toxin (BT) injection into the laryngeal muscles has been a standard treatment for spasmodic dysphonia (SD). However, few high-quality clinical studies have appeared, and BT is used off-label in most countries. We performed a multicenter,...
https://doi.org/10.1002/mus.27161
Muscle & Nerve; Dwyer CD, Leclerc AA et. al.
Dec 31st, 2020 - Despite use of qualitative laryngeal electromyography (LEMG) guided botulinum toxin A (BoNT-A) injection for treatment of adductor spasmodic dysphonia (AdSD), unsatisfactory injections and complete "misses" remain problematic. We aimed to determin...
News 1 results
https://www.mdedge.com/ccjm/article/103773/drug-therapy/noncosmetic-uses-botulinum-toxin-otolaryngology?channel=133
Michael S. Benninger, MD, Libby J. Smith, DO, FAOCO
Nov 1st, 2015 - Botulinum toxin is commonly used to treat movement disorders of the head and neck. It was first used to treat focal eye dystonia (blepharospasm) and laryngeal dystonia (spasmodic dysphonia) and is now also used for other head and neck dystonias, m.
